Bertaglia Emanuele, Shah Dipen
Department of Cardiology, Civic Hospital, Mirano (VE), Italy.
Ital Heart J. 2005 Dec;6(12):946-9.
Typical atrial flutter is readily abolished by creating a line of block along the isthmus between the tricuspid annulus and the inferior vena cava. However, postablation atrial fibrillation occurs frequently, and its occurrence increases during the follow-up. Preablation atrial fibrillation is the most important risk factor for postablation atrial fibrillation occurrence. Among patients with preablation atrial fibrillation, patients with drug-induced atrial flutter present a lower risk of postablation atrial fibrillation than patients with spontaneous preablation atrial fibrillation. Patients with preablation lone atrial flutter also present a significant risk of atrial fibrillation development as time passes. Hence, they must be advised of the risk of recurrent symptoms and late atrial fibrillation, and closely followed up despite successful transisthmic ablation. Patients with atrial fibrillation after transcatheter isthmus ablation should be offered catheter-based pulmonary vein isolation, particularly if atrial fibrillation occurs despite continuation of antiarrhythmic drug therapy.
通过在三尖瓣环和下腔静脉之间的峡部创建一条阻滞线,典型心房扑动很容易被消除。然而,消融术后心房颤动频繁发生,且在随访期间其发生率增加。消融术前心房颤动是消融术后发生心房颤动的最重要危险因素。在消融术前有心房颤动的患者中,药物性心房扑动患者消融术后发生心房颤动的风险低于自发性消融术前心房颤动患者。消融术前孤立性心房扑动患者随着时间推移也有发生心房颤动的显著风险。因此,尽管经峡部消融成功,仍必须告知他们复发症状和晚期心房颤动的风险,并密切随访。经导管峡部消融术后发生心房颤动的患者应接受基于导管的肺静脉隔离,尤其是在继续抗心律失常药物治疗的情况下仍发生心房颤动时。